masoprocol has been researched along with Bone Loss, Osteoclastic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kukita, A; Kukita, T; Li, YJ; Ninomiya, Y; Qu, P; Sanematsu, K; Takano, T; Watanabe, T | 1 |
Bonewald, LF; Gallwitz, WE; Gaskell, SJ; Lee, CH; Mundy, GR; Qiao, M; Raftery, M; Roodman, GD | 1 |
2 other study(ies) available for masoprocol and Bone Loss, Osteoclastic
Article | Year |
---|---|
Nordihydroguaiaretic acid inhibition of NFATc1 suppresses osteoclastogenesis and arthritis bone destruction in rats.
Topics: Animals; Arthritis, Experimental; Bone Resorption; Calcium Signaling; Cell Differentiation; Cell Line; Dose-Response Relationship, Drug; Female; Male; Masoprocol; Mice; Mice, Inbred C57BL; NFATC Transcription Factors; Osteitis; Osteoclasts; RANK Ligand; Rats; Rats, Sprague-Dawley | 2012 |
5-Lipoxygenase metabolites of arachidonic acid stimulate isolated osteoclasts to resorb calcified matrices.
Topics: Acid Phosphatase; Animals; Arachidonate 5-Lipoxygenase; Arachidonic Acids; Bone Matrix; Bone Resorption; Chickens; Culture Media, Conditioned; Endopeptidases; Female; Flurbiprofen; Humans; Hydroxyeicosatetraenoic Acids; Indomethacin; Leukotrienes; Lipoxygenase Inhibitors; Masoprocol; Osteoclasts; Tartrates; Ultraviolet Rays | 1993 |